Back to Search Start Over

Convenient synthesis and X-ray determination of 2-amino-6 H -1,3,4-thiadiazin-3-ium bromides endowed with antiproliferative activity.

Authors :
Tawfeek HN
Abdelmoez A
Dahlous KA
Youssif BGM
Bräse S
Rissanen K
Nieger M
El-Sheref EM
Source :
RSC advances [RSC Adv] 2024 Jun 27; Vol. 14 (25), pp. 17866-17876. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).
Publication Year :
2024

Abstract

A new series of 1,3,4-thiadiazin-3-ium bromide derivatives 9a-g were prepared as a six-member ring by interactions between 4-substituted thiosemicarbazides 8a-e and α-halo ketones 2a,b. The reaction was conducted using hydrazine-NH <subscript>2</subscript> and yielded a hexagonal shape. The structures of all obtained compounds have been verified using IR, NMR spectra, mass spectrometry, elemental analysis, and X-ray crystallography. The X-ray crystallographic analysis of compounds 9a and 9b has revealed that the salt is formed with the nitrogen atom N3 when the aromatic substituents 9a and 9d are present, but in the case of compounds 9b, 9c, 9e, 9f, and 9g with the aliphatic substituent, the salt is formed outside the ring. Compounds 9a-g were evaluated for antiproliferative activity as multitargeted inhibitors. Results revealed that targets 9a-g displayed good antiproliferative activity, with GI <subscript>50</subscript> ranging from 38 nM to 66 nM against a panel of four cancer cell lines compared to the reference Erlotinib (GI <subscript>50</subscript> = 33 nM). Compounds 9a, 9c, and 9d were the most potent antiproliferative derivatives, with GI <subscript>50</subscript> values of 43, 38, and 47 nM, respectively. Compounds 9a, 9c, and 9d were evaluated for their inhibitory activity against EGFR, BRAF <superscript>V600E</superscript> , and VEGFR-2. The in vitro experiments demonstrated that the compounds being examined exhibit potent antiproliferative properties and have the potential to function as multitargeted inhibitors. In addition, the western blotting investigation demonstrated the inhibitory effects of 9c on EGFR, BRAF <superscript>V600E</superscript> , and VEGFR-2.<br />Competing Interests: The authors state that they do not have any known competing financial interests or personal links that could appear to have influenced the work disclosed in this study.<br /> (This journal is © The Royal Society of Chemistry.)

Details

Language :
English
ISSN :
2046-2069
Volume :
14
Issue :
25
Database :
MEDLINE
Journal :
RSC advances
Publication Type :
Academic Journal
Accession number :
38939040
Full Text :
https://doi.org/10.1039/d4ra02531h